Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.39 -0.17 (-0.92%)
As of: Oct 22, 2026 · 12:08 PM EDT

Sarepta Therapeutics (SRPT) Short-Term Debt issuances (2026)

Updated

Sarepta Therapeutics (SRPT) recorded Short-Term Debt issuances of $175 million in Q2 2026, down 30.0% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Short-Term Debt issuances (2026) Analysis & Trends

On a TTM basis, Sarepta Therapeutics' Short-Term Debt issuances came in at $425 million as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn -
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn 707.00 Mn
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn -
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn -
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn -
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn -
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn -
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Sarepta Therapeutics 1.94 Bn -1.29 Bn 251.87 Mn 175.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175.00 Mn
Mar 31, 2026 250.00 Mn
API Access

Sarepta Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=SRPT&period=max&api_key=YOUR_API_KEY